Dermatofibrosarcoma Protuberans
📧 Sign up to get email alerts when something new happens for Dermatofibrosarcoma Protuberans.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes [Phase 2]
Phase 2 clinical trial evaluating imatinib mesylate in patients with various activated tyrosine kinase-driven malignancies, including hypere…
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Phase II Pazopanib Study in Advanced Dermatofibrosarcomas [Phase 2]
A Phase II study of pazopanib in advanced dermatofibrosarcoma protuberans was terminated.
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
A Phase 2 trial evaluating saracatinib (AZD0530) in adults with recurrent, locally advanced, or metastatic soft tissue sarcoma has completed…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans [Phase 2]
Phase 2 trial evaluating imatinib mesylate in patients with locally recurrent or metastatic dermatofibrosarcoma protuberans.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma [Phase 2]
A Phase 2 study evaluating imatinib mesylate in patients with locally advanced or metastatic dermatofibrosarcoma protuberans or giant cell f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-29Clinical Trial Update: Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans [Phase 2]
A Phase 2 neoadjuvant trial of imatinib in dermatofibrosarcoma protuberans completed, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2011-07-29Clinical Trial Update: Imatinib in Dermatofibrosarcoma Protuberans (DFSP) [Phase 1, Phase 2]
Phase 1/2 trial of imatinib for dermatofibrosarcoma protuberans has completed.